Clinical Trial Update: Pedunculopontine Nucleus Stimulation for Gait Disorders in Parkinson's Disease [Phase 1, Phase 2]

View source ↗

Summary

This update reports on the completion of Phase 1/Phase 2 clinical trials evaluating pedunculopontine nucleus stimulation as a gait-disorder therapy in Parkinson…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Pedunculopontine Nucleus Stimulation

Snippet

Sponsor: Pitié-Salpêtrière Hospital | Conditions: Parkinson's Disease | Phase 1, Phase 2 | Status: COMPLETED